P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,236.80
-36.75 (-0.59%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 10.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
707.67
-44.01
-6.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
707.67
-44.01
-6.22%
Raw Material Cost
137.67
50.97
86.70
170.10%
Purchase of Finished goods
34.95
62.88
-27.93
-44.42%
(Increase) / Decrease In Stocks
-10.23
20.58
-30.81
-149.71%
Employee Cost
109.89
200.44
-90.55
-45.18%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
224.55
-43.78
-19.50%
Total Expenditure (Excl Depreciation)
453.05
559.42
-106.37
-19.01%
Operating Profit (PBDIT) excl Other Income
210.61
148.25
62.36
42.06%
Other Income
8.98
4.29
4.69
109.32%
Operating Profit (PBDIT)
219.59
152.54
67.05
43.96%
Interest
0.24
3.92
-3.68
-93.88%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
148.62
70.73
47.59%
Depreciation
11.52
18.12
-6.60
-36.42%
Profit Before Tax
207.83
130.50
77.33
59.26%
Tax
53.11
31.95
21.16
66.23%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
98.55
56.17
57.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
98.55
56.17
57.00%
Equity Capital
16.60
61.16
-44.56
-72.86%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
16.11
77.09
478.52%
Diluted Earnings per share
93.21
16.11
77.10
478.58%
Operating Profit Margin (Excl OI)
31.73%
20.95%
0.00
10.78%
Gross Profit Margin
33.05%
21.00%
0.00
12.05%
PAT Margin
23.31%
13.93%
0.00
9.38%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024